Treatment outcome has become increasingly the subject of focus in the area of psychological research. Often contested has been the ever widening debate over the efficacy of medication treatment versus psychotherapy. Using a sample of 62 adults diagnosed with Major Depression, this study compared the treatment outcome of those receiving just medication versus those receiving medication and psychotherapy. The data were collected for subjects receiving treatment over a six month period. The study examined whether those receiving medication and therapy experienced a higher degree of improvement as measured by the Basis-32 symptom identification scale which was completed by all participants both pre-treatment and after six months of treatment.
INTRODUCTION PURPOSE OF THE STUDY
The purpose of this research was to measure the outcome that therapy offers when combined with medication in the treatment of depression. Improvement was assessed using the BASIS-32 symptom identification scale which is completed at the onset of treatment and at the end of six months. This research is an attempt to support the notion that the inclusion of both medication and therapy will provide the best treatment option for Major Depression.
Availability of Information:
There is a significant amount of research supporting therapy as an effective intervention for the treatment of depression (Paykel, et al., 1999) . There is also a significant amount of research supporting that anti-depressant medication is an effective treatment intervention (Elkin, et al., 1989) . There have been numerous studies comparing the effectiveness of different types of therapy, as well as, different types of medication (Shea, et al., 1992) . Recently, there has been an increase in the study of combining psychotherapy and medication in the treatment of depression (Moyer, 2004) .
Research has shown that compliance issue arise during the treatment process, such as, during the initial six weeks which is approximately how long it takes for medication to reach a therapeutic response. Also, during remission when patients feel well enough to attempt to discontinue medication. It is here where therapy can be both supporting and beneficial (DeRubeis, et al, 2002) .
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Need for the Study:
The primary focus of this research is to determine if therapy positively influences treatment outcome. There are critical phases during the treatment process for depression that are connected to treatment outcome and are vital during the course of treatment in order for patients to be least distressed and most comfortable throughout the process (Spigset & Bjorn, 1999) . This research will determine if therapy combined with medication versus just medication will improve treatment outcome. This being established, perhaps a closer look at the critical phases of treatment will show that some modes of psychotherapy may be more effective than others. The initial six weeks of treatment is a critical phase in the treatment process. It is here where patients are initially assessed and often prescribed medication. Most Seratonin Specific Reuptake Inhibitors (SSRIs) take six to eight weeks before patients notice improvement with their symptoms.
Some research indicates that therapy is important during this phase of treatment (Paykel, et al., 1999) . Without support during this period, many patients are likely to drop out of treatment or to suffer unnecessarily. Also, toward the end of treatment may be considered another critical phase when patients may want to titrate off of their medications and try to move on with their lives without medication. Often during this period cognitive therapy can be beneficial (Paykel, et al., 1999) . Helping patients rebuild positive thought processes in this stage is critical. Educating patients about certain thought processes which encourage depressive responses versus thought process that are recovery centered can be taught during this stage (Paykel et al., 1999) . Psychotherapy cannot be defined with any precision. Psychotherapy could be defined as a formal process of interaction between two parties, each party usually consisting of one person but with the possibility that there may be two or more people in each party. The interaction is for the purpose of ameliorating distress in one of the two parties (i.e., client) relative to any of the following areas of disability or malfunction:
cognitive functions (disorders of thinking), affective functions (suffering or emotional discomforts), or behavioral functions (inadequacy of behavior). The interaction would require that the therapist have some theory of personality origins and development. The therapist would need to posses a high level of self-understanding, and experience with change along with some method of treatment logically related to the theory the therapist has taken into practice. Also, the therapist should possess the professional and legal approval to act as a therapist (Corsini, 1989) . It is important to note that some modes of psychotherapy may fit the definition better than others. This definition would be more suited for the more non-directive psychotherapies, such as, person centered. Whereas, more directive therapy, such as, behavior modification would rely less on the interaction and more on the actions created in treatment.
OMM: Out-patient Medication Maintenance (OMM) is a community based not-forprofit program that provides outpatient treatment for adults who are assessed to have a need for medication and counseling services yet do not fulfill the criteria for case management services which would include home visits, medication monitoring, and access to entitlements. The criteria for admission into the OMM program are as follows:
A) You must be 18 years old or older. Once an individual is admitted into the OMM program, the option of therapy is offered to all participants. The therapy offered is supportive in nature but also provides coping strategies for patients to manage problem areas. During therapy the client is encouraged to discuss experiences as related to affect, thought processes and day to day stressors. In this study the therapy would be classified as "supportive therapy" initially in treatment with more focus on goals and objectives as treatment progresses. Perhaps a more detailed review of the thought processes which may be reinforcing the depression and the introduction of techniques which can intervene to break patterns that may have interpersonal therapy. This study was also the first study to directly compare two different forms of psychotherapy (Elkin, et al., 1989) . The study's results indicated that all of the treatments were effective. The Imipramine-CM was most effective, the least effective being the placebo, and the psychotherapies in the middle. The two therapies were equally effective. In follow up studies (Shea, 1992) , results showed that there were no significant differences in relapse between each group, and there were no significant differences in those achieving a full recovery in each group. This study involved a four-month period of acute treatment followed by an additional year of treatment for those who showed improvement in the initial phase. Among those who continued into the second phase of the study, 75% of patients who underwent cognitive therapy avoided a relapse, compared to 60% of patients on medication and 19% of those receiving a placebo pill. Results also showed that a brief course of cognitive therapy was better than a similarly brief course of medication in the year long continuation phase. These results suggest that even after termination, a brief course of cognitive therapy may offer enduring protection (DeRubeis, et al., 2002) . Paykel et al., (1999) studied the effects of cognitive therapy on relapse prevention of residual depression. The study indicated that depressed patients in partial remission with residual symptoms following anti-depressant treatment are at high risk for a complete relapse. There is evidence that cognitive therapy may reduce relapse rates in depression.
Results of the study indicated that cognitive therapy significantly reduced relapse rates for acute major depression and persistent and severe residual symptoms (Paykel, et al., 1999) .
In another study examining the economic aspects of managed care plans and psychotherapy treatment alternatives, a discovery was made that a new trend had been developing regarding the allocation of funds toward treatment research (Stoil, 1999) . In Medication versus Medication and Therapy Treatment Outcome 7 his study, Stoil revealed that practitioners have long complained that managed care threatens the viability of psychotherapy as a treatment for mental health problems. Stoil also discovered that reimbursement policies favor medication over talk therapies (Stoil, 1999.) . Mental health clinicians argue that practice guidelines and reimbursement policies enforced by managed care could result in the elimination of long-term psychotherapy. While conducting this research Stoil's attention had turned to the federal government's role in fostering this situation (Stoil, 1999) A recent study presented at the 157 th annual meeting of the American Psychiatric Association (APA) supported that psychotherapy combined with antidepressant medication is more effective than pharmaceutical monotherapy in treating depression (Moyer, 2004) . In this study 167 patients were randomized to receive either combination psychotherapy and antidepressant pharmacology or pharmacology alone. Of the combination therapy group 72% experienced a remission of their depression symptoms compared with 57% of patients in the pharmacotherapy alone (Moyer, 2004) .
Other psychiatrists who presented research at the 157 th meeting of the (APA) were The intent of this study was to examine whether psychotherapy combined with medication compared to medication treatment alone improves treatment outcome in Major Depression. This study also measured whether the groups would differ across the various domains of functioning within the Basis-32. Measuring these domains would provide a more specific measure of symptom improvement across various areas of the patient's functioning.
Sample and Population:
The sample consisted of 62 adults between the ages of 27 and 56 who completed at least 6 months of treatment at a community mental health center in Rhode Island. All of the subjects carried a diagnosis of Major Depression and were treated with medication.
Individual therapy was available to all subjects. The therapy involved the patient developing a positive supportive relationship with the therapist. The therapy included the monitoring of symptoms, as well as, intervening with techniques that will interrupt unproductive thought patterns that may reinforce depression. Assisting and educating patients to identify their own negative thought processes was of major importance for the development of their own personal insight. Identifying strengths that were beneficial to treatment was also explored.
The group receiving medication and therapy will be referred to as the MT group. The group receiving just medication will be referred to as the JM group. Each group will be Medication versus Medication and Therapy Treatment Outcome 10 measured for change in Basis-32 scores during the six months of treatment. The degree of symptoms that were present after 6 months of treatment to the JM group will be referred to as JMA6M. The degree of symptoms that were present after six months of treatment to the medication and therapy group will be referred to as MTA6M group. In another study concerning reliability and validity, Klinkenberg, Cho, and Vieweg, (1998) found that the Basis-32 had good internal consistency and test-retest reliability on most subscales. Subjects were randomly assigned to either a self-report or an interview Medication versus Medication and Therapy Treatment Outcome 12 condition. The study indicated that subjects rated themselves higher in the self report condition than in the interview condition. Results of this study indicated that the group assigned to the self report condition was more internally consistent than the group assigned to the interview condition (Klinkenberg, et al., 1998) .
The Basis-32 is divided into five functional domains which include: The focus of this study emphasized the use of the Basis-32 as a whole. The five domains were tested individually as well with increased focus on the depression domain to assess how the two groups compared with depressive symptoms.
Methods used in Data Analysis:
The research was classified as Ex Post Facto. The primary analysis was to determine if the two groups would differ on the mean number of improved psychiatric symptoms after receiving treatment at a mental health center for six months. The clinical records for all subjects were reviewed to classify them into the MT or JM group. T-tests were calculated to measure any differences between means for the two groups. The t-test level of significance was set at .05. A baseline analysis was completed between groups initially to determine if the MT and JM groups differed on their initial level of distress, a t-test was also run on the initial Basis-32 scores for the two groups. An analysis within groups was conducted first within the JM group between initial treatment and after six Within groups:
When comparing the JM group's Basis-32 pre-treatment scores with JMA6M there was a significant amount of improvement with symptoms t(10) = 9.83, p<.05. When comparing the MT group's pre-treatment scores with MTA6M there was also a significant amount of improvement with symptoms t(10) = 7.89, p<.05.
Between groups:
Although both groups showed significant improvement in symptoms after treatment, the results reveal significantly greater improvement of symptoms or a significant patient feels prepared to disengage from treatment (Spigset & Bjorn, 1999) .
Therapy may be helpful as a support to avoid relapse during the transition. These critical phases were not taken into consideration during the analysis of this study and perhaps could be implications for further research. Also, the social, family and environmental supports of each patient were not taken into consideration during the analysis of this study. If support is sufficient in these areas, then therapy may not be necessary.
The findings of this study indicated that both groups benefited from the use of medication. The MT group improved to a greater degree that the JM group and also improved significantly more in three of the five domains expressed in the Basis-32. Of special significance would be the domain of Depression which improved most significantly in this study. The depression domain symptoms are most relevant to the subjects studied. A significant improvement here indicates that the subjects not only have benefited from the addition of therapy but have improved the circumstances of their diagnosis.
Limitation of the Study:
Due to the small size of this group results should be cautiously interpreted. The extent to which this group is generalizeable is very questionable. In this study the sample included adults of a lower socioeconomic scale who were already receiving treatment.
Due to the study being ex post facto and not having within the sample a group treated with therapy only limits the results we will receive. Also, this study can be difficult to generalize it to the CMHC due to the small sample size and lack of control.
Implications for Further Research:
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There has been a fair amount of research available on the effectiveness or necessity of psychotherapy in the treatment of depression. This is an important area to continue to research. Focusing on the initial six weeks of treatment may be important. It is during this time that patients are most distressed and more likely to be less compliant with their medication regimen. It would be interesting to compare drop out rates for those receiving just medication versus those receiving combined treatment.
When patients have been successfully treated and are in remission, less intensive residual symptoms may continue and need to be addressed without medication. Specific types of therapy could be analyzed here to rule out what may or may not be effective at the beginning of treatment, and also when clients are in remission. There is much research studying the independent effects of medication and psychotherapy treatment for depression. There is less research available that looks at combined treatment as the preferred treatment.
Research in this area could lead to more comprehensive treatment alternatives which include both medication and therapy in a more inclusive and strategic manner to treat each individual. Perhaps it makes sense to incorporate therapy into the initial phase of treatment and explain the benefits it can present. Also, to possibly educate patients with information about thought processes that may be counter-productive versus beneficial for patients while in treatment and in remission. As indicated in studies mentioned earlier, the pharmacological approach appeared to be becoming the dominant mode of treatment research in the late 1990s. Designs used specifically to study medications consistently revealed positive results which reinforced this trend. Some changes have begun to occur within the American Psychiatric Association (APA) that may be leading to a more balanced approach to treatment. It is clear that both psychotherapy and medication are effective modes of treatment. Which is most effective has yet to be proven. It is likely or it appears that if depression is treated by both medication and therapy together, the best outcome may be reached.
